We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+5.55%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$712B
AUM Growth
+$31.8B
Cap. Flow
+$2.48B
Cap. Flow %
0.35%
Top 10 Hldgs %
21.18%
Holding
2,600
New
72
Increased
1,394
Reduced
949
Closed
59

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$2.27B
2
LLY icon
Eli Lilly
LLY
+$1.64B
3
NVDA icon
NVIDIA
NVDA
+$1.59B
4
RHT
Red Hat Inc
RHT
+$1.55B
5
BKNG icon
Booking.com
BKNG
+$1.12B

Sector Composition

Rank Sector Weight
1 Technology 18.88%
2 Healthcare 16.96%
3 Financials 13.79%
4 Consumer Discretionary 13.57%
5 Industrials 9.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FIT
2451
DELISTED
Fitbit, Inc. Class A common stock
FIT
$128K ﹤0.01%
29,093
+735
+3% +$3.7K
GCAP
2452
DELISTED
Gain Capital Holdings, Inc.
GCAP
$128K ﹤0.01%
30,970
FNJN
2453
DELISTED
Finjan Holdings, Inc.
FNJN
$128K ﹤0.01%
57,850
+7,800
+16% +$21K
AMAG
2454
DELISTED
AMAG Pharmaceuticals
AMAG
$127K ﹤0.01%
12,663
+100
+0.8% +$1.08K
NE
2455
DELISTED
Noble Corporation
NE
$127K ﹤0.01%
68,133
+500
+0.7% +$1.18K
LKSD
2456
DELISTED
LSC Communications, Inc.
LKSD
$125K ﹤0.01%
34,120
+16,300
+91% +$96K
ARC
2457
DELISTED
ARC Document Solutions, Inc.
ARC
$124K ﹤0.01%
60,563
GPRE icon
2458
Green Plains
GPRE
$1.06B
$119K ﹤0.01%
11,033
+100
+0.9% +$1.49K
GOGO icon
2459
Gogo Inc
GOGO
$383M
$118K ﹤0.01%
29,740
+100
+0.3% +$486
SELF
2460
Global Self Storage
SELF
$58.6M
$118K ﹤0.01%
31,400
RMTI icon
2461
Rockwell Medical
RMTI
$29.6M
$114K ﹤0.01%
344
+2
+0.6% +$1.02K
CLNE icon
2462
Clean Energy Fuels
CLNE
$384M
$111K ﹤0.01%
41,459
+200
+0.5% +$581
IMNN icon
2463
Imunon
IMNN
$6.77M
$110K ﹤0.01%
308
FPRX
2464
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$109K ﹤0.01%
18,003
-1,004,444
-98% -$9.6M
AHT
2465
Ashford Hospitality Trust
AHT
$19.8M
$107K ﹤0.01%
37
+1
+3% +$4.68K
ERII icon
2466
Energy Recovery
ERII
$397M
$107K ﹤0.01%
10,307
+100
+1% +$984
ACTG icon
2467
Acacia Research
ACTG
$455M
$106K ﹤0.01%
35,868
+100
+0.3% +$312
TPCO
2468
DELISTED
Tribune Publishing Company Common Stock
TPCO
$105K ﹤0.01%
13,184
+51
+0.4% +$527
LTS
2469
DELISTED
Ladenburg Thalmann Financial Services Inc
LTS
$105K ﹤0.01%
30,540
+565
+2% +$1.95K
HBP
2470
DELISTED
Huttig Building Products, Inc.
HBP
$104K ﹤0.01%
40,446
GROW icon
2471
US Global Investors
GROW
$38.7M
$102K ﹤0.01%
56,500
SRNE
2472
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$102K ﹤0.01%
38,372
+25,200
+191% +$90.7K
RAIL icon
2473
FreightCar America
RAIL
$243M
$100K ﹤0.01%
17,100
-154
-0.9% -$994
AKBA icon
2474
Akebia Therapeutics
AKBA
$248M
$99K ﹤0.01%
20,423
+846
+4% +$4.81K
ACH
2475
Accendra Health
ACH
$93.1M
$99K ﹤0.01%
30,925
+100
+0.3% +$341

Similar funds

T. Rowe Price Associates's Q2 2019 Portfolio in Review

As of Q2 2019, T. Rowe Price Associates held 2,600 positions worth $712B, up 4.7% from $680B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

T. Rowe Price Associates's Q2 2019 filing shows 72 new, 1,394 increased, 949 reduced and 59 closed positions. Its largest new stake was Alcon: 36,020,796 shares worth $2.23B. The largest sale was UnitedHealth, an estimated $2.27B.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.

  • T. Rowe Price Associates's largest Q2 2019 buy was Alcon: 36,020,796 shares worth $2.23B.
  • T. Rowe Price Associates added most to Linde in Q2 2019, an estimated $1.34B increase.
  • T. Rowe Price Associates's biggest Q2 2019 reduction was UnitedHealth, cutting an estimated $2.27B.
  • T. Rowe Price Associates fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $609M.
  • T. Rowe Price Associates's ten largest holdings make up 21% of its $712B portfolio in Q2 2019.
  • T. Rowe Price Associates opened 72 new positions and closed 59 in Q2 2019.
  • T. Rowe Price Associates's portfolio value rose 4.7% quarter-over-quarter to $712B.

Based on T. Rowe Price Associates's 13F filing for Q2 2019, filed 15 Aug 2019.